Equities

Sharps Technology Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert
STSS:NAQ

Sharps Technology Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)1.70
  • Today's Change-0.05 / -2.86%
  • Shares traded197.65k
  • 1 Year change-98.35%
  • Beta2.2008
Data delayed at least 15 minutes, as of Feb 10 2026 21:00 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Sharps Technology, Inc. is a medical device and pharmaceutical packaging company. The Company is engaged in offering patented smart-safety syringe products to the healthcare industry. The Company's smart safety syringe products, such as Securgard, Sologard, and Sharps Provensa, are ultra-low waste syringes that incorporate both passive and active safety and reuse prevention features. It Sharps Securegard and Sologard safety syringe product lines incorporate both active and passive safety features and have been designed to address the primary administration concerns with syringe delivery systems, including accidental needlestick injuries, wasted medicine/dead space and reuse prevention. It also offers products that are designed with specialized copolymer technology to support the prefillable syringe market segment. It has a manufacturing facility in Hungary and is pursuing plans to expand its manufacturing capacity in the United States.

  • Revenue in USD (TTM)2.51m
  • Net income in USD-104.37m
  • Incorporated2022
  • Employees5.00
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Icecure Medical Ltd2.98m-15.29m40.76m64.00--4.38--13.70-0.2586-0.25860.05010.13490.1960.823524.3946,484.38-100.74-61.14-155.92-77.1135.0650.17-513.95-343.951.90--0.00--1.9215.35-4.55---6.51--
Neuroone Medical Technologies Corp12.10m-3.61m40.81m18.00--5.72--3.37-0.0784-0.07840.30120.14141.501.6316.79672,094.40-44.63-113.64-61.95-152.0867.3060.94-29.80-223.443.47--0.1519--250.3544.4170.73---7.76--
Precision Optics Corporation Inc21.58m-6.11m41.07m90.00--3.76--1.90-0.8505-0.85053.011.421.095.005.90239,722.70-30.82-13.63-45.79-19.5114.9929.56-28.30-11.580.785-28.850.1375---0.068513.98-95.85--7.81--
Cytosorbents Corp34.35m-10.59m42.14m149.00--4.67--1.23-0.19-0.190.560.14360.73442.184.89230,553.30-22.63-34.58-28.22-41.8077.0270.00-30.81-62.081.71--0.6176--14.517.3729.16---15.13--
electroCore, Inc.29.84m-14.16m42.78m73.00------1.43-1.70-1.703.59-0.14051.412.6329.39408,698.60-66.70-65.38-126.40-87.8786.0480.72-47.46-159.341.33--1.20--57.0960.1536.89------
EUDA Health Holdings Ltd5.16m-2.06m45.37m117.0077.67----8.790.01550.08760.1483-0.09982.49--17.1044,104.96-100.77------22.39---40.53--0.2084-46.54----8.22---108.62------
Neuraxis Inc3.36m-8.37m46.45m21.00--18.90--13.81-1.02-1.020.40590.23110.97187.9441.74160,111.00-217.93---1,360.57--84.34---224.24--1.55-97.220.0789--9.18--42.21------
Spectral AI Inc23.17m-16.37m47.57m78.00------2.05-0.7206-0.72060.9706-0.3011.7228.4112.12297,025.70-121.66------45.01---70.64--0.8252-11.99----63.83--26.56------
Heartbeam Inc0.00-20.62m49.25m16.00--120.95-----0.6638-0.66380.000.01180.00----0.00-432.60-142.55-792.01-190.45------------0.00-------32.85------
Sharps Technology Inc2.51m-104.37m50.74m5.00--0.1116--20.20-690.20-690.200.395715.680.0111.81--502,354.00-45.86-86.10-47.44-125.430.1489---4,155.30--3.67--0.0173------5.54--65.50--
Nutriband Inc2.28m-34.59m51.87m13.00--6.86--22.76-3.07-3.070.20030.6210.21749.9617.72---121.91-66.47-134.92-78.0433.5037.16-560.85-340.947.35--0.022--2.6041.99-91.10------
Alpha Pro Tech Ltd59.10m3.68m55.53m130.0015.700.881412.330.93970.34150.34155.466.080.8031.6410.62454,584.605.0013.855.2314.5838.2140.646.2312.787.70--0.000.00-5.544.39-6.215.5424.04--
Medinotec Inc11.43m2.34m58.78m51.0025.0810.6924.695.140.19940.19940.97340.46791.874.047.03224,166.5038.33--49.87--58.25--20.48--3.8937.940.00008--81.53--633.61------
CS Diagnostics Corp0.00-341.62k59.50m5.00---------531,454.00-531,454.00----0.00-------579.61-1,264.84-----------209,220.50------------32.83------
Pulmonx Corp91.66m-56.75m63.52m291.00--1.06--0.693-1.41-1.412.281.460.59971.477.20314,996.60-37.13-26.27-42.91-28.9673.3072.91-61.91-89.484.15--0.3821--22.0120.787.31--14.98--
QT Imaging Holdings Inc11.50m-19.51m63.81m20.00------5.55-2.09-2.091.27-0.9391.201.346.57574,821.50-204.52---4,313.85--50.81---169.73--0.4745-2.0280.26--11,987.88---132.34------
Data as of Feb 10 2026. Currency figures normalised to Sharps Technology Inc's reporting currency: US Dollar USD

Institutional shareholders

18.85%Per cent of shares held by top holders
HolderShares% Held
Schonfeld Strategic Advisors LLCas of 30 Sep 20251.54m5.99%
Saba Capital Management LPas of 16 Jan 20261.51m5.89%
Pantera Advisors LLCas of 30 Sep 20251.15m4.48%
The Vanguard Group, Inc.as of 31 Dec 2025341.38k1.33%
Vanguard Fiduciary Trust Co.as of 31 Dec 2025164.48k0.64%
OMERS Administration Corp.as of 30 Sep 202581.33k0.32%
Vanguard Global Advisers LLCas of 31 Dec 202515.77k0.06%
Morgan Stanley & Co. LLCas of 30 Sep 202513.08k0.05%
XTX Markets LLCas of 30 Sep 202512.11k0.05%
Geode Capital Management LLCas of 30 Sep 202511.44k0.05%
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.